Literature DB >> 26970805

Dissolution Profile of Nimesulide from Pharmaceutical Preparations for Oral Use.

Biljana Tubić, Alija Uzunović, Saša Pilipović, Žarko Gagić.   

Abstract

Nimesulide belongs to the group of semi-selective COX-2 inhibitors, widely used in solid oral formulations. In the present work the influence of surfactants among other drug excipients, as well as particle size of the active substance and the effects of medium pH on the dissolution rate of nimesulide from solid pharmaceutical forms. For that purpose, four different preparations containing 100 mg nimesulide per tablet and available in the market of Bosnia and Herzegovina (labeled here as A, B, C and D) were studied. The test for the assessment of dissolution profiles of the formulations was performed in surfactant-free dissolution medium pH 7.5. The dissolution profiles were compared by calculating difference (f1), and similarity (f2) factors. The increasing dissolution medium pH value from 7.5 to 7.75 resulted in a significant increase of nimesulide dissolution rate from the examined formulations. Also, the results showed that particle size affects to a great extent the dissolution rate and the best results were achieved with micronized nimesulide. The presence of the surfactants among the other excipients expressed a negligible effect on the dissolution profile.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26970805     DOI: 10.17344/acsi.2015.2168

Source DB:  PubMed          Journal:  Acta Chim Slov        ISSN: 1318-0207            Impact factor:   1.735


  2 in total

1.  Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.

Authors:  Yingyu Guo; Kaijun Gou; Baixue Yang; Yumei Wang; Xueyu Pu; Sanming Li; Heran Li
Journal:  Molecules       Date:  2019-09-30       Impact factor: 4.411

2.  A survey and optical microscopy in pilot comparative analysis of generic and original nimesulide granules.

Authors:  Pavlo Leonenko; Natalia Ostanina; Yuliia Kokoieva; Mykhaylo Levin; Halyna Leonenko; Oleksii Gumeniuk; Olena Doroshenko; Yana Nikolaieva
Journal:  Heliyon       Date:  2021-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.